Search
for
Sort by
Research 151–180 of 274
- Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Peptide Therapy in Aesthetic, Metabolic, and Endocrine Medicine
- EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Exploring the role of two polypeptide nanofiber gels derived from RADA16-I self-assembly in accelerating burn wound healing
- Abstracts from the 2024 WDS Forum - virtual option
- Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Editor's Highlights — September 2024
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Metabolic syndrome — a new definition and management guidelines
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Farmácia da Boa Hora, Porto e nos Serviços Farmacêuticos do Hospital Lusíadas, Porto
- PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis